A pattern is emerging in enterprise artificial intelligence that has little to do with model benchmarks, funding rounds, or regulatory headlines. Every major technology shift eventually produces its own recognisable contract, and
MoreAlembic Pharmaceuticals has received a formal warning letter from the U.S. Food and Drug Administration targeting its bioequivalence research facility in Vadodara, India. The warning letter, dated July 10, 2026, follows an
MoreRepresentative Rich McCormick, a Republican from Georgia, introduced the Biotechnology Diplomacy Leadership Act on July 16, 2026, formally designated as H.R. 9755. The bill aims to strengthen America’s position in what is
MoreA federal judge has found that a lawsuit brought by President Trump against the IRS sought to “manipulate the judicial process,” resulting in sanctions against attorneys involved. The controversy centres on an
MoreSkadden Arps faces mounting political pressure over its conflict of interest concerns tied to its deal with the Trump administration and its simultaneous legal work for Intel. Senators Richard Blumenthal and Adam
MoreOn 20 July 2026, Judge R. Gary Klausner of the Central District of California declared Vivek Shah a vexatious litigant in a significant privacy law ruling. The decision came in the case
MorePresident Donald Trump signed three proclamations on July 20, 2026, imposing additional 50% duties on specified Canadian goods covering motor vehicles, alcoholic beverages and dairy products. The tariffs mark the first-ever use
MoreNinth Circuit Judge Lawrence VanDyke has drawn sharp criticism after filing a dissent that urged the Supreme Court to summarily reverse his own court’s Second Amendment rulings. The dissent came in the
MoreIndia’s pharmaceutical and healthcare regulatory landscape continued to evolve significantly during the first half of 2026, with authorities introducing a range of new measures and frameworks. The changes were aimed at simplifying
MoreThe University of Michigan’s athletic department has faced a series of high-profile controversies over recent years, drawing intense public and legal scrutiny from multiple directions. Those controversies include the Connor Stallions sign-stealing
More
